Functional convalescent plasma antibodies and pre-infusion titers shape the early severe COVID-19 immune response
Convalescent plasma (CP) has been trialed as a therapy for SARS-CoV-2 symptoms, but its heterogenous nature precludes uniform outcomes. Here the authors perform deep profiling of CP, as well as plasma of CP recipients before and after transfer, to find CP-mediated, spike/nucleocapsid-focused modulat...
Enregistré dans:
Auteurs principaux: | , , , , , , , , , , , , , , |
---|---|
Format: | article |
Langue: | EN |
Publié: |
Nature Portfolio
2021
|
Sujets: | |
Accès en ligne: | https://doaj.org/article/5214fb7ba9d240e5bff4799c7e668657 |
Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|